Antagonizing Bcl-2 Family Members Sensitizes Neuroblastoma and Ewing’s Sarcoma to an Inhibitor of Glutamine Metabolism
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antagonizing Bcl-2 Family Members Sensitizes Neuroblastoma and Ewing’s Sarcoma to an Inhibitor of Glutamine Metabolism
Authors
Keywords
Glutamine, Cancer treatment, Apoptosis, Amino acid metabolism, Drug metabolism, Ewing sarcoma, Cell metabolism, Metabolic pathways
Journal
PLoS One
Volume 10, Issue 1, Pages e0116998
Publisher
Public Library of Science (PLoS)
Online
2015-01-24
DOI
10.1371/journal.pone.0116998
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cellular Fatty Acid Metabolism and Cancer
- (2013) Erin Currie et al. Cell Metabolism
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- Metabolic targets for cancer therapy
- (2013) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- A simple test for synergy for a small number of combinations
- (2013) Steven J. Novick STATISTICS IN MEDICINE
- Non-glucose metabolism in cancer cells—is it all in the fat?
- (2012) Swethajit Biswas et al. CANCER AND METASTASIS REVIEWS
- ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
- (2012) Guoliang Qing et al. CANCER CELL
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
- (2012) C. Bodur et al. CURRENT MEDICINAL CHEMISTRY
- Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
- (2011) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?
- (2009) J. L. Ordonez et al. CANCER RESEARCH
- c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry
- (2009) F Morrish et al. ONCOGENE
- Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
- (2009) R J DeBerardinis et al. ONCOGENE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Brick by brick: metabolism and tumor cell growth
- (2008) Ralph J DeBerardinis et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Global Regulation of Nucleotide Biosynthetic Genes by c-Myc
- (2008) Yen-Chun Liu et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search